An uniquely purified HCV NS3 protease and NS4A21-34 peptide form a highly active serine protease complex in peptide hydrolysis

Protein Expression and Purification

Volumn 16, Issue 3, 1999, Pages 440-447

  Sardana, Vinod V ^a   Blue, Jeffrey T ^a   Zugay Murphy, Joan ^a   Sardana, Mohinder K ^a   Kuo, Lawrence C ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; ENZYME PURIFICATION; ENZYMIC HYDROLYSIS; HEPATITIS C VIRUS; PROTEIN DEGRADATION; PROTEINASE; SEPHAROSE; VIRUS DETECTION;

ESCHERICHIA COLI; FELIS CATUS; HEPATITIS C VIRUS;

EID: 0033180510     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1090     Document Type: Article

References (47)

1. Choo Q.-L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Kuo G., Choo Q.-L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E., Tagtmeier G. E., Bonino F., Colombo M., Lee W. S., Kuo C., Berger K., Shister J. R., Overby L. R., Bradley D. W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science. 244:1989;362-364.
3. Chien D., Choo Q. L., Tabrizi A., Kuo C., McFacrland J., Berger K., Lee C., Shuster J., Nguyen T., Moyer D., Tong M., Furuta S., Omata M., Tegtmeyer G., Alter H., Schiff E., Jeffers L., Houghton M., Kuo G. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: Reevaluation of the role of HCV in liver disease. Proc. Natl. Acad. Sci. USA. 89:1992;10011-10015.
4. Choo Q. L., Richman K. H., Ham J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P. J., Weiner A. J., Bradley D. W., Kuo G., Houghton M. Genetic organization and diversity of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;2451-2455.
5. Kato M., Hijikata M., Oostsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. 87:1990;9524-9528.
6. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onoshi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65:1991;1105-1113.
7. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993;1385-1395.
8. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
9. Tomei L., Failla C., Santolini E., De Francesco R., La Monica N. NS3 is a serine protease required for processing hepatitis C virus polyprotein. J. Virol. 67:1993;4017-4026.
10. Bartenschlager R., Ahlborn-Laake L., Mous J., Jacobsen H. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J. Virol. 67:1993;3835-3844.
11. Failla C., Tomei L., De Francesco R. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J. Virol. 69:1995;1769-1777.
12. Lin C., Pragai B. M., Grakoui A., Xu J., Rice C. M. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J. Virol. 68:1994;8147-8157.
13. Failla C., Tomei L., De Francesco R. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J. Virol. 68:1994;3753-3760.
14. Lin C., Thomson J. A., Rice C. M. A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J. Virol. 69:1995;4373-4380.
15. Shimizu Y., Kamaji K., Masuho Y., Yokota T., Inoue H., Sudo K., Satoh S., Shimotohno K. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J. Virol. 70:1996;127-132.
16. Lin C., Rice C. M. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: Establishment of a cell-free trans-processing assay. Proc. Natl. Acad. Sci. USA. 92:1995;7622-7626.
17. Tomei L., Failla C., Vitale R. L., Bianchi E., De Francesco R. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J. Gen. Virol. 77:1996;1065-1070.
18. Bartenschlager R., Lohmann V., Wilkinson T., Koch J. O. Complex formation between the NS3 serine-type proteinase of the hepetitis C virus and NS4A and its importance for the polyprotein maturation. J. Virol. 69:1995;7519-7528.
19. Butkiewicz N. J., Wendel M., Zhang R., Jubin R., Pichardo J., Smith E. B., Hart A. M., Ingram R., Durkin J., Mui P. W., Murray M. G., Ramanathan L., Dasmahapatra B. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides - Identification of sequence and critical residues of NS4A for the cofactor activity. Virology. 225:1996;328-338.
20. D'Souza E., D. A., Grace K., Sangar D. V., Rowlands D. J., Clarke B. E. In-vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease. J. Gen. Virol. 76:1995;1729-1736.
21. Kakiuchi N., Hijikata M., Komoda Y., Tanji Y., Hirowatari Y., Shimotohno K. Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrates. Biochem. Biophys. Res. Commun. 210:1995;1059-1065.
22. Steinkuhler C., Urbani A., Tomei L., Sardana M., Bianchi E., Pessi A., De Francesco R. Activity of purified hepatitis C virus protease NS3 on peptide substrates. J. Virol. 70:1996;6694-6700.
23. Shoji I., Suzuki T., Chieda S., Sato M., Harada T., Chiba T., Matsuura Y., Miyamura T. Proteolytic activity of NS3 serine protease of hepatitis C virus effeciently expressed in Escherichia coli. Hepatology. 22:1995;1648-1655.
24. Mori A., Yamada K., Kimura J., Koide T., Yuasa S., Yamada E., Miyamura T. The N-terminal region of NS3 serine proteinase of hepatitis C virus is important to maintain its enzymatic integrity. FEBS Lett. 378:1996;37-42.
25. Steinkuhler C., Tomei L., De Francesco R. In-vitro activity of hepatitis C virus protease NS3 purified from recombinant baculovirus-infected sf9 cells. J. Biol. Chem. 271:1996;6367-6373.
26. Suzuki T., Sato M., Chieda S., Shoji I., Harada T., Yamadawa Y., Watabe S., Matsuura Y., Miyamura T. In-vivo and in-vitro transcleavage activity of hepatitis C virus proteinase expressed by recombinant baculoviruses. J. Gen. Virol. 76:1995;3021-3029.
27. Urbani A., Bianchi E., Narjes F., Tramontano A., De Francesco D., Steinkuhler C., Pessi A. Substrate specificity of the hepatitis C virus serine protease NS3. J. Biol. Chem. 272:1997;9204-9209.
28. Vishnuvardhan D., Kakiuchi N., Urvil P. T., Shimotohno K., Kumar P. K. R., Nishikawa S. Expression of highly active recombinant NS3 protease domain of hepatitis C virus in E. coli. FEBS Lett. 402:1997;209-212.
29. Hong Z., Ferrari E., Wright-Minogue J., Chase R., Risano C., Seelig G., Lee C. G., Kwong A. D. Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J. Virol. 70:1996;4261-4268.
30. Landro J. A., Raybuck S. A., Luong Y. P. C., O'Malley E. T., Harbeson S. L., Morgenstern K. A., Rao G., Livingston D. J. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: Elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping. Biochemistry. 36:1997;9340-9348.
31. Zhang R., Durkin J., Windsor W. T., McNemar C., Ramanathan L., Le H. U. Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides. J. Virol. 71:1997;6208-6213.
32. Kwong A. D., Kim J. L., Rao G., Lipovsek D., Raybuck S. A. Hepatitis C virus NS3/NS4A protease. Antiviral Res. 40:1998;1-18.
33. Tanji Y., Hijikata M., Satoh S., Kaneko T., Shimotohno K. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J. Virol. 69:1995;1575-1581.
34. Kim J. L., Morgenstern K. A., Lin C., Fox T., Dwyer M. D., Landro J. A., Chamber S. P., Markland W., Lapre C. A., O'Melley E. T., Harbeson S. L., Rice C. M., Murco M. A., Caron P. R., Thomson J. A. Crystal structure of the hepatitis C Virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell. 87:1996;343-355.
35. Love R. A., Parge H. E., Wickersham J. A., Hostomsky Z., Habuka N., Moomaw E. W., Adachi T., Hostomska Z. The crystal structure of the hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell. 87:1996;331-342.
36. Yan Y., Li Y., Munshi S., Sardana V., Cole J., Sardana M. K., Steinkuhler C., Tomei L., DeFrancesco R., Kuo L. C., Chen Z. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form. Protein Sci. 7:1998;837-847.
37. Bianchi E., Urbani A., Biasiol G., Brunetti M., Pessi A., Defrancesco R., Steinkuhler C. Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide. Biochemistry. 36:1997;7890-7897.
38. Kim D. W., Gwack Y., Han J. H., Choe J. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biohem. Biophys. Res. Commun. 215:1995;160-166.
39. Jin L., Peterson D. L. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch. Biochem. Biophys. 323:1995;47-53.
40. Kanai A., Tanabe K., Kohara M. Poly(U) binding activity of hepatitis C virus NS3 protein, a putative RNA helicase. FEBS Lett. 376:1995;221-224.
41. Suzich J. A., Tamura J. K., Palmer-Hill F., Warrener P., Grakoui A., Rice C. M., Feinstine S. M., Collett M. S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparision with the related pestivirus and flavivirus enzymes. J. Virol. 67:1993;6152-6158.
42. Morgenstern K. A., Landro J. A., Hsiao K., Lin C., Gu Y., Su M. S.-S., Thomson J. A. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected cos cells. J. Virol. 71:1997;3767-3775.
43. Sardana V. V., Schlabach A. J., Graham P., Bush B. L., Condra J. H., Culberson J. C., Gotlib L., Graham D. J., Kohl N. E., LaFemina R. L., Schneider C. L., Wolanski B. S., Wolfgang J. A., Emini E. A. Biochemistry. 33:1994;2004-2010.
44. Mangel W. F., Toledo D. L., Brown M. T., Martin J. H., McGrath W. J. Characterization of three components of human adenovirus proteinase activity in-vitro. J. Biol. Chem. 271:1996;536-543.
45. Sardana V. V., Wolfgang J. A., Veloski C. A., Long W. J., LeGrow K., Wolanski B., Emini E. A., LaFemina R. L. Peptide substrate cleavage specificity of the human cytomegalovirus protease. J. Biol. Chem. 259:1994;14337-14340.
46. Darke P. L., Chen E., Hall D. L., Sardana M. K., Veloski C. A., LaFemina R. L., Shafer J. A., Kuo L. C. Purification of active herpes simplex virus-1 protease expressed in Escherichia coli. J. Biol. Chem. 269:1994;18708-18711.
47. Hall D. L., Darke P. L. Activation of the herpes simplex virus type-1 protease. J. Biol. Chem. 270:1995;22697-22700.